Please provide your email address to receive an email when new articles are posted on . “The challenge of modern cancer therapy is still to cure but also to prevent late effects, especially in ...
Only 11 cases of adverse events (AEs) were reported over a 6-year time frame, the investigators found, following administration of chimeric antigen receptor T-cell therapy (CAR T). A new retrospective ...
Please provide your email address to receive an email when new articles are posted on . The number of long-term blood or marrow transplant survivors in the United States is expected to exceed 500,000 ...
As Hong Kong moves toward implementing landmark legislation to protect people's end-of-life care wishes, a research team at the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has ...
Adjuvant nivolumab (NIVO) plus ipilimumab (IPI) for resected high-risk stages IIIC/IV melanoma (MEL). This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not ...
A breast cancer patient in her 30s presented for assessment of disseminated erythematous papules and nodules 9 months after undergoing her final chemotherapy treatment. Her medical history showed that ...
Using the provincial cancer registry (Ontario, Canada), and adopting a nested case-control approach, we identified CCS diagnosed and/or treated for a primary malignancy before age 18 years (1986-2015) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results